SKYSEQ
Live / Registered — Registered (as of 08 Apr 2025)
What this means for you
Registered since 08 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90590474
- Registration number
- 7754868
- Mark type
- Stylized text
- Filed
- 19 Mar 2021
- Published for opposition
- 05 Jul 2022
- Registered
- 08 Apr 2025
- Attorney of record
- Peter Kunin
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing
Owner
- Skyhawk Therapeutics, Inc., Waltham, MA, US
- Skyhawk Therapeutics, Inc., Waltham, MA, US
- Skyhawk Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 08 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Nov 2024 — ASSIGNED TO LIE
- 24 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Oct 2024 — NON-FINAL ACTION E-MAILED
- 18 Oct 2024 — SU - NON-FINAL ACTION - WRITTEN
- 27 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 May 2024 — USE AMENDMENT FILED
- 06 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL